Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
+835K
-
Total reported value, excl. options
-
$149M
-
Value change
-
+$6.98M
-
Put/Call ratio
-
2.19
-
Number of buys
-
39
-
Number of sells
-
-41
-
Price
-
$8.12
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q3 2021
110 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q3 2021.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
of 65.9M outstanding shares and own 27.88% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.56M shares), VANGUARD GROUP INC (1.87M shares), Skylands Capital, LLC (1.84M shares), AVENIR CORP (1.4M shares), Neuberger Berman Group LLC (1.26M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.15M shares), Redmile Group, LLC (1.04M shares), Sargent Investment Group, LLC (964K shares), Soleus Capital Management, L.P. (800K shares), and STATE STREET CORP (722K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.